文献速递瓣膜外科冠心病外科

重度主动脉瓣狭窄合并冠心病的完全经导管与外科途径对比:系统综述与Meta分析

Complete transcatheter versus surgical approach to aortic stenosis with coronary artery disease: A systematic review and meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-08-18

本Meta分析纳入2项随机对照试验和6项观察性研究共104,220例重度主动脉瓣狭窄合并冠心病患者,比较TAVR+PCI与SAVR+CABG。TAVR+PCI组随访期全因死亡和冠状动脉再干预风险更高,30天永久起搏器植入率和血管并发症更高,但30天急性肾损伤更低。再住院、心肌梗死、卒中及30天死亡两组相似。

要点

  • TAVR+PCI组随访期全因死亡风险更高(HR 1.35,95%CI 1.11-1.65,P=.003)。
  • TAVR+PCI组随访期冠状动脉再干预风险更高(HR 4.14,95%CI 1.74-9.86,P=.001)。
  • TAVR+PCI组30天急性肾损伤更低(OR 0.32,95%CI 0.20-0.50,P=.0001)。

主要发现

  • TAVR+PCI组随访期全因死亡风险更高(HR 1.35,95%CI 1.11-1.65,P=.003)。
  • TAVR+PCI组随访期冠状动脉再干预风险更高(HR 4.14,95%CI 1.74-9.86,P=.001)。
  • TAVR+PCI组30天永久起搏器植入率更高(OR 3.79,95%CI 1.61-8.95,P=.002)。
  • TAVR+PCI组围术期血管并发症更高(OR 6.97,95%CI 1.85-26.30,P=.004)。
  • TAVR+PCI组30天急性肾损伤更低(OR 0.32,95%CI 0.20-0.50,P=.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This meta-analysis aimed to evaluate outcomes of transcatheter aortic valve replacement (TAVR) with percutaneous coronary intervention (PCI) versus surgical aortic valve replacement (SAVR) with coronary artery bypass grafting (CABG). METHODS: The MEDLINE, EMBASE, and Cochrane Library databases were searched through November 2021 to identify studies comparing TAVR + PCI and SAVR + CABG for severe aortic stenosis with concurrent coronary artery disease. Outcomes of interest were all-cause mortality, repeat coronary intervention, rehospitalization, myocardial infarction, and stroke during follow-up, and 30-day periprocedural outcomes. RESULTS: Two randomized controlled trials and 6 observational studies including a total of 104,220 patients (TAVR + PCI, n = 5004; SAVR + CABG, n = 99,216) were included. The weighted mean follow-up period was 30.2 months. TAVR + PCI was associated with greater all-cause mortality and coronary reintervention during follow-up period (hazard ratio, 1.35; 95% confidence interval [CI], 1.11-1.65; P = .003, hazard ratio, 4.14; 95% CI, 1.74-9.86; P = .001, respectively), 30-day permanent pacemaker implantation rate (odds ratio [OR], 3.79; 95% CI, 1.61-8.95; P = .002), and periprocedural vascular complications (OR, 6.97; 95% CI, 1.85-26.30; P = .004). In contrast, TAVR + PCI was associated with a lower rate of 30-day acute kidney injury (OR, 0.32; 95% CI, 0.20-0.50; P = .0001). Rehospitalization, myocardial infarction, stroke during follow-up, and other periprocedural outcomes including 30-day mortality were similar in both groups. CONCLUSIONS: In patients with severe aortic stenosis and coronary artery disease, TAVR + PCI was associated with greater all-cause mortality at follow-up compared with SAVR + CABG. Heart Team approach to assess TAVR candidacy remains imperative.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sakurai Y, Yokoyama Y, Fukuhara S, et al. Complete transcatheter versus surgical approach to aortic stenosis with coronary artery disease: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2022. PMID: 36150940. doi:10.1016/j.jtcvs.2022.08.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。